EMA Authorised: Procysbi (mercaptamine bitartrate) — Chiesi Farmaceutici S.p.A

View source ↗

Summary

The European Medicines Agency authorised Procysbi (mercaptamine bitartrate) for the treatment of cystinosis, with Chiesi Farmaceutici S.p.A as the marketing aut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystinosis

Drugs mentioned

• Procysbi (mercaptamine bitartrate)

Snippet

Status: Authorised. Therapeutic area: Cystinosis. MAH: Chiesi Farmaceutici S.p.A. Decision date: 05/09/2025